Diabetes mellitus and pancreatitis as a complication of L-asparaginase therapy.
Charan
V D
VD
Department of Hematology, All India Institute of Medical Sciences, New Delhi.
Desai
N
N
Singh
A P
AP
Choudhry
V P
VP
D000208:Acute Disease; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects* / Q000096:biosynthesis / Q000191:economics; D002648:Child; D003920:Diabetes Mellitus / Q000139:chemically induced* / Q000188:drug therapy; D004317:Doxorubicin / Q000008:administration & dosage; D016527:Drug Costs; D004926:Escherichia coli; D006801:Humans; D008297:Male; D010195:Pancreatitis / Q000139:chemically induced* / Q000188:drug therapy; D016973:Pectobacterium carotovorum; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D011239:Prednisolone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D011239:Prednisolone; D001215:Asparaginase